Valvular & structural heart disease

Performance of Transcatheter Direct Annuloplasty in Patients With Atrial and Nonatrial Functional Tricuspid Regurgitation

JACC Cardiovasc IntervPublished Multicentre cohort study

Authors' conclusion

Direct TTVA effectively reduces TR in both A-FTR, which is a strong and independent predictor of achieving TR ≤II, and NA-FTR.

Study context

Population
Patients undergoing transcatheter direct tricuspid valve annuloplasty (transcatheter tricuspid valve annuloplasty (TTVA)) for functional tricuspid regurgitation (TR)
Participants
165 consecutive patients
Exposure
Atrial functional tricuspid regurgitation (A-FTR) vs nonatrial functional tricuspid regurgitation (NA-FTR) in patients undergoing TTVA
  • A-FTRn = 62
  • NA-FTRn = 103reference
Outcome
TR ≤II at discharge
Follow-up
Discharge
Methodological detailsconsecutive patients
  • Consecutive patients

Main finding

As reported in the abstract

P = 0.001

TR grade at discharge significantly reduced vs baseline in both subtypes
P < 0.001

Observational data: associations, not effects.

Further findings

OutcomeOR (95% CI)P value
TR ≤II at 30 days, A-FTR phenotype as predictor (multivariate)Multivariate analysis5.8 (2.1–16.1)P < 0.001

Mortality · up to 1 year

P = 0.011

HF hospitalization · up to 1 year

P = 0.188

Functional class vs baseline · up to 1 year

Functional class significantly improved vs baseline in both phenotypes
P < 0.001

Original publication

Performance of Transcatheter Direct Annuloplasty in Patients With Atrial and Nonatrial Functional Tricuspid Regurgitation. JACC Cardiovasc Interv. Published 24 June 2024. doi:10.1016/j.jcin.2024.04.013

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.